Pretreatment calprotectin level as a potential predictor of therapeutic response to tofacitinib in rheumatoid arthritis patients.

Sun YS, Chen PK, Hung HC, Chen DY

Open source

DOI
10.1007/s10067-026-08496-y
Published
2026 Nov 3
Container
Clinical rheumatology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s10067-026-08496-y,
  title = {Pretreatment calprotectin level as a potential predictor of therapeutic response to tofacitinib in rheumatoid arthritis patients.},
  author = {Sun YS and Chen PK and Hung HC and Chen DY},
  year = {2026},
  journal = {Clinical rheumatology},
  doi = {10.1007/s10067-026-08496-y},
  url = {https://doi.org/10.1007/s10067-026-08496-y}
}

RIS

TY  - JOUR
TI  - Pretreatment calprotectin level as a potential predictor of therapeutic response to tofacitinib in rheumatoid arthritis patients.
AU  - Sun YS
AU  - Chen PK
AU  - Hung HC
AU  - Chen DY
PY  - 2026
JO  - Clinical rheumatology
DO  - 10.1007/s10067-026-08496-y
UR  - https://doi.org/10.1007/s10067-026-08496-y
ER  - 

APA

YS, S., PK, C., HC, H., & DY, C. (2026). Pretreatment calprotectin level as a potential predictor of therapeutic response to tofacitinib in rheumatoid arthritis patients.. Clinical rheumatology. https://doi.org/10.1007/s10067-026-08496-y

Source records